Wallace Akerley

27.5k citations
159 papers · 5.5k · 1 hit paper · h-index 36

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Brain Metastases and Treatment
    • Prostate Cancer Treatment and Research
  • Oncology top 1%
    • Lung Cancer Research Studies
    • Cancer Treatment and Pharmacology

Papers in

    • Lung Cancer Treatments and Mutations 60
    • Lung Cancer Diagnosis and Treatment 22
    • Brain Metastases and Treatment 16
    • Cancer Treatment and Pharmacology 24
    • Lung Cancer Research Studies 16
    • Colorectal Cancer Treatments and Studies 13

Wallace Akerley

151 papers receiving 5.2k citations

Wallace Akerley's Hit Papers

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer 2011 · 327 citations
3270+5+10Years since publication100200300

Peers

Wallace Akerley
Comparison fields: 5 of 112
  • Pulmonary and Respiratory Medicine 2.6k
  • Oncology 2.0k
  • Hepatology 441
  • Genetics 351
  • Otorhinolaryngology 127
Replace Cristina Nanni with:
Cristina Nanni Italy
Otilia Dalesio Netherlands
Wilfried Eberhardt Germany
F. Mornex France
Rogério Lilenbaum United States
Wayne L. Hofstetter United States
Joan Carles Spain
Mark R. Green United States
James D. Brierley Canada
Rafat Ansari United States
Wallace Akerley relative to Cristina Nanni Italy Cristina Nanni's profile →
Citations per field
00.5×1.5×2×2.5×
Cristina Nanni · 1×
Citations per year

Countries citing papers authored by Wallace Akerley

Since Specialization
Citations

This map shows the geographic impact of Wallace Akerley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wallace Akerley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wallace Akerley more than expected).

Fields of papers citing papers by Wallace Akerley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wallace Akerley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wallace Akerley. The network helps show where Wallace Akerley may publish in the future.

Co-authors

The 25 scholars most cited alongside Wallace Akerley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wallace Akerley Line = papers co-authored together Wallace Akerley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000498
2 2007365
3
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer
Hit paper breakdown →
2011327
4 2013326
5 2001280
6 1998264
7 2015219
8 1998200
9 2009198
10 1996168
11 1994124
12
Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
199894
13 201078
14 201275
15 199774
16 199369
17 200263
18 201861
19 201358
20 200357

About Wallace Akerley

Wallace Akerley is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 159 papers that have together received 5.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (60 papers), Cancer Treatment and Pharmacology (24 papers), Lung Cancer Diagnosis and Treatment (22 papers), Lung Cancer Research Studies (16 papers), Brain Metastases and Treatment (16 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Genomics and Diagnostics (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Oncology (2.0k citations), Hepatology (441 citations), Genetics (351 citations) and Otorhinolaryngology (127 citations). Wallace Akerley has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Howard Safran, Bernard F. Cole, William W. Mayo-Smith, Peter V. Kavanagh, Ronald J. Zagoria, Damian E. Dupuy, Michael Glantz, H. Choy, Joachim von Pawel and James E. Herndon. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer, Cancer Research and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact